These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2974879

  • 1. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
    Köhler C, Karlsson-Boethius G.
    J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
    [Abstract] [Full Text] [Related]

  • 2. In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride.
    Köhler C, Karlsson-Boethius G.
    J Neural Transm; 1989; 76(1):13-28. PubMed ID: 2523467
    [Abstract] [Full Text] [Related]

  • 3. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 4. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH, Nielsen EB.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):315-8. PubMed ID: 2948372
    [Abstract] [Full Text] [Related]

  • 5. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
    Köhler C, Hall H, Gawell L.
    Eur J Pharmacol; 1986 Jan 21; 120(2):217-26. PubMed ID: 3948920
    [Abstract] [Full Text] [Related]

  • 6. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M, Hidaka K, Nakamura Y.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):177-82. PubMed ID: 2576228
    [Abstract] [Full Text] [Related]

  • 7. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C, Hall H, Ogren SO, Gawell L.
    Biochem Pharmacol; 1985 Jul 01; 34(13):2251-9. PubMed ID: 4015674
    [Abstract] [Full Text] [Related]

  • 8. Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo.
    Van der Werf JF, Sebens JB, Korf J.
    Life Sci; 1986 Jul 14; 39(2):155-60. PubMed ID: 3724366
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 10. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.
    Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P.
    Neuroscience; 1991 Aug 16; 40(3):657-71. PubMed ID: 2062437
    [Abstract] [Full Text] [Related]

  • 11. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.
    Bischoff S, Gunst F.
    J Recept Signal Transduct Res; 1997 Aug 16; 17(1-3):419-31. PubMed ID: 9029505
    [Abstract] [Full Text] [Related]

  • 12. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T, Ström P, de Paulis T, Stensland B, Csöregh I, Lundin K, Hall H, Ogren SO.
    J Med Chem; 1991 Mar 16; 34(3):948-55. PubMed ID: 1672158
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR, Watanabe M, Seeman P.
    J Neurochem; 1985 Apr 16; 44(4):1168-77. PubMed ID: 2579204
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 16; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH.
    Eur J Pharmacol; 1988 Jan 27; 146(1):113-20. PubMed ID: 2895008
    [Abstract] [Full Text] [Related]

  • 16. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May 27; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 17. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C, Haglund L, Ogren SO, Angeby T.
    J Neural Transm; 1981 May 27; 52(3):163-73. PubMed ID: 7198139
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    Dewar KM, Montreuil B, Grondin L, Reader TA.
    J Pharmacol Exp Ther; 1989 Aug 27; 250(2):696-706. PubMed ID: 2527300
    [Abstract] [Full Text] [Related]

  • 19. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267
    [Abstract] [Full Text] [Related]

  • 20. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
    Florijn WJ, De Boer T, Tonnaer JA, Van Nispen JW, Versteeg DH.
    Eur J Pharmacol; 1991 May 25; 207(1):43-50. PubMed ID: 1680721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.